Human Chorionic Gonadotropin Supplementation Prior to In-vitro Fertilization Treatment in Poor Responders
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
In an era of delayed fertility plans, there is increasing need for fertility treatment in
older women with poor response. Human chorionic gonadotropin (hCG) supplementation prior to
treatment, as a thecal stimulant, may improve folliculogenesis and ovarian response.